Emtriva

Product manufactured by Gilead Sciences, Inc.

Application Nr Approved Date Route Status External Links
NDA021500 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Emtriva ® Is Indicated In Combination With Other Antiretroviral Agents For The Treatment Of Hiv-1 Infection. Emtriva, A Nucleoside Analog Hiv-1 Reverse Transcriptase Inhibitor, Is Indicated In Combination With Other Antiretroviral Agents For The Treatment Of Hiv-1 Infection. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Emtricitabine EMTRICITABINE ZINC3629271

Comments